BURGDORF, Switzerland--(BUSINESS WIRE)--The new Sanitized® MedX 200s active ingredient series, which has been used with success in the plastics of medical equipment, makes a contribution to reducing the risk of Healthcare-Associated Infections, HAI.

The results from current studies underscore that even the antibiotic resistant bacteria strain NDM-1 can be contained. These studies were carried out by an independent laboratory in London, UK. The first tests already confirmed the effectiveness against MRSA as well as against antibiotic resistant bacteria. SANITIZED also identified other active substances with a very interesting profile against the same bacteria.

The active ingredients imbedded in the polymers inhibit the growth of bacteria populations on the surface of treated medical devices—durably and reliably.

“We intend to extend our Sanitized® MedX 200s portfolio soon. This will allow us to enlarge our offer in medical device applications, including textile applications,” explained Dr. Bruno Piastra, Product Manager Polymer Additives at SANITIZED. The medical device sector was designated as a business pillar in our growth strategy for the next years.

SANITIZED AG is the leading worldwide producer of antimicrobial hygiene function and material protection for textiles and plastics. For over 50 years this pioneering Swiss company has used the latest technology to develop individual antimicrobial hygiene solutions. SANITIZED is committed to responsible ecological practices with products that use only scientifically researched and registered antimicrobial active ingredients, which have undergone strict, internationally approved risk assessments for people and the environment. The company also offers support for marketing and technical queries, comprehensive testing services, and a universally recognized brand and licensing concept.

Contacts